Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine.
T cell responses are involved in vaccine-induced immunity to pertussis but no easy-to-monitor, serological markers are available to assess these responses. The lymphocyte activation gene-3 (CD223) molecule is present on, and released by, activated T helper (Th) 1 cells, whereas CD30 molecules have been associated with Th2 immune responses. Starting from the recent knowledge of the cytokine profile induced by pertussis vaccination, we examined the levels of soluble (s)CD223 and sCD30 proteins in child recipients of acellular pertussis (aP) and diphtheria-tetanus (DT) vaccines and in children receiving DT vaccine only, as control. The correlation of the two proteins with specific antibody and T cell responses was assessed. The main findings are: i) sCD223 and sCD30 levels are inversely related, suggesting that the two markers are the expression of different and counter-regulated T-cell responses; ii) sCD30 level correlated with induction of T cell proliferation to pertussis vaccine antigens and antibody response to pertussis toxin. Overall, sCD30 and sCD223 levels seem to be promising candidate markers to assess the induction of Th-type responses in vaccine recipients.
Department of Infectious, Parasitic and Immune-mediated diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. ausiello@iss.it
C M
CM
Ausiello
R
R
Palazzo
F
F
Spensieri
F
F
Urbani
M
M
Massari
F
F
Triebel
M
M
Benagiano
M M
MM
D'Elios
G
G
Del Prete
A
A
Cassone
D000907:Antibodies, Bacterial / Q000032:analysis / Q000096:biosynthesis; D015703:Antigens, CD / Q000032:analysis / Q000378:metabolism*; D015415:Biomarkers; D002648:Child; D016207:Cytokines / Q000096:biosynthesis*; D004311:Double-Blind Method; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D017730:Ki-1 Antigen / Q000032:analysis / Q000378:metabolism*; D010567:Pertussis Vaccine / Q000494:pharmacology*; D018417:Th1 Cells / Q000276:immunology* / Q000378:metabolism; D018418:Th2 Cells / Q000276:immunology*; D022282:Vaccines, Acellular / Q000494:pharmacology; D000093322:Lymphocyte Activation Gene 3 Protein
D000907:Antibodies, Bacterial; D015703:Antigens, CD; D015415:Biomarkers; D016207:Cytokines; D017730:Ki-1 Antigen; D010567:Pertussis Vaccine; D022282:Vaccines, Acellular; D000093322:Lymphocyte Activation Gene 3 Protein; C000720326:Lag3 protein, human